Best Healthcare Mutual Funds for Defensive Investing
Healthcare mutual funds can cushion your portfolio when markets fall. See top fund picks, tax notes, and how much to allocate as an Indian investor.
A cardiologist in Chennai once told me that his clinic's revenue barely moved during the 2008 crash. People still got sick. They still needed stents, bypasses, and blood pressure tablets. The stock market could fall 50 percent, but a blocked artery does not check the Nifty before it decides to act.
That is the entire investment case for healthcare mutual funds in one sentence. When growth stocks crater and cyclicals stall, hospitals, diagnostic labs, and pharma manufacturers keep earning. Not because they are exciting. Because they sell things people cannot postpone.
## Why Healthcare Is a Defensive Sector
Defensive funds are not funds that never fall. They are funds whose earnings hold up when the economy slows. Healthcare sits alongside FMCG and utilities in that bucket, and for good reason.
Consider the demand structure. A person with diabetes buys insulin every month regardless of whether GDP grows at 6 percent or 4 percent. A hospital bed in a metro city runs at 70 percent occupancy through boom and bust. Diagnostic chains see volumes rise when people get anxious about their health, which tends to happen more, not less, during stressful periods.
Then there is the pricing power. Pharma companies with patented drugs or complex generics can raise prices without losing customers. Hospitals can nudge up procedure rates annually. Compare that to an airline or a carmaker, which has to discount heavily the moment demand softens.
The sector also benefits from a structural tailwind that has nothing to do with market cycles: aging populations. India's elderly population is projected to nearly double by 2050. The US spends roughly 17 percent of its GDP on healthcare. India spends closer to 3 percent. That gap is a long runway, not a one-year trade.
## What "Defensive" Actually Means for Returns
Here is where we need to be honest. Defensive does not mean high returns in a bull market. If the Nifty jumps 25 percent in a year, a healthcare fund might deliver 12 to 15 percent. You are trading upside for stability. That is the deal.
The payoff shows up in drawdowns. In the 2020 crash, the Nifty fell about 38 percent from peak to trough. Healthcare funds fell too, but several recovered their losses within months, well before the broader market. In 2022, when global tech and growth stocks bled, pharma held relatively firm.
So who should own these funds?
- Retirees or near-retirees who cannot afford a 40 percent portfolio hit
- Salaried investors in their 40s who already hold aggressive equity funds and want a stabiliser
- Anyone expecting a market correction and wanting to stay invested without losing sleep
If you are 26 and have a 30-year horizon, a pure healthcare fund is probably not your first choice. You want growth. But a 10 to 15 percent allocation to healthcare inside a diversified portfolio makes sense at almost any age.
## Sectoral Funds for Defense: The Trade-Off You Must Accept
A sectoral fund bets on one industry. That concentration cuts both ways. Healthcare is defensive relative to the market, but it is not immune to its own problems. US drug pricing legislation, a bad clinical trial, or a regulatory crackdown on Indian pharma factories can hammer the sector for quarters at a time.
The 2018-2019 period is instructive. Indian pharma faced US FDA warnings on several plants, pricing pressure in the generic market, and weak earnings. Healthcare funds lagged the Nifty for nearly two years. Investors who bought them expecting safety got a lesson in patience instead.
The lesson: a defensive sector is not a bond. It is still equity. You need a five-year horizon minimum, and you need to size the position so a 20 percent drawdown does not force you to sell.
## Our Take: Three Healthcare Funds Worth a Look
We are not going to pretend there is one perfect fund. But if you want healthcare exposure, these three have built track records that justify attention. Check expense ratios and exit loads on your platform before investing, because they vary.
### 1. Nippon India Pharma Fund
One of the oldest in the category, running since 2004. It holds a mix of domestic pharma, hospitals, and some global healthcare exposure. The long tenure means it has survived multiple cycles, which matters more than a hot three-year number.
### 2. ICICI Prudential Pharma Healthcare and Diagnostics (PHD) Fund
This one leans into diagnostics and hospitals alongside pharma. That mix captures the domestic healthcare spend story, not just exports. If you believe India's private healthcare build-out is the bigger opportunity, this fund reflects that view.
### 3. SBI Healthcare Opportunities Fund
A steady, large-cap tilted option. It tends to hold the bigger names in pharma and healthcare, which means lower volatility than some peers but also less explosive upside. Good for a core defensive holding.
A quick comparison:
| Fund | Style | Best For |
|---|---|---|
| Nippon India Pharma | Diversified pharma and hospitals | Long-term core holding |
| ICICI Pru PHD | Diagnostics and hospitals tilt | Domestic healthcare story |
| SBI Healthcare Opportunities | Large-cap focused | Lower volatility |
If you want just one, we would pick based on what you already own. Holding a large-cap index fund? The ICICI or Nippon option adds something different. Holding mid-cap heavy funds? The SBI option balances it out.
## Tax and Practical Notes for Indian Investors
Equity mutual funds, including sectoral ones, are taxed at 12.5 percent on long-term gains above Rs 1.25 lakh a year (holding period over 12 months). Short-term gains are taxed at 20 percent. These rates apply to the current regime, so confirm them before you file.
Sectoral funds also work better as a satellite, not a core. We would cap healthcare at 10 to 20 percent of your equity portfolio. If you already own a diversified equity fund, check its holdings. Many flexi-cap and large-cap funds already carry 5 to 8 percent in pharma. Do not double up by accident.
One more thing. Do not buy a healthcare fund because you think the market is about to crash. Buy it because you want the earnings profile. Timing a defensive rotation is as hard as timing anything else.
## FAQ
### Are healthcare mutual funds safe during a recession?
Safer than most equity sectors, but not safe in absolute terms. Demand holds up, which cushions earnings. Share prices can still fall 20 to 30 percent in a broad selloff.
### How much of my portfolio should go into a healthcare fund?
For most salaried investors, 10 to 20 percent of the equity portion. Treat it as a satellite position, not the foundation.
### Do I need a healthcare fund if I already own a diversified equity fund?
Not necessarily. Check your existing fund's sector allocation first. If it already holds 6 to 8 percent in pharma, adding a dedicated fund pushes you into an accidental overweight.
## Related on this site
- [How to Start a Systematic Investment Plan (SIP) in Mutual Funds: A Beginner's Guide](/finance/blog/how-to-start-a-systematic-investment-plan-sip-in-mutual-funds-a-beginner-s-guide)
- [Fed Decisions and Your Mutual Funds: What Indian Investors Should Know](/finance/blog/fed-decisions-and-your-mutual-funds-what-indian-investors-should-know)
- [New Stock Market Pricing Mechanism: What It Means for Your Trades](/finance/blog/new-stock-market-pricing-mechanism-what-it-means-for-your-trades-2)
Frequently asked questions
1. Nippon India Pharma Fund
One of the oldest in the category, running since 2004. It holds a mix of domestic pharma, hospitals, and some global healthcare exposure. The long tenure means it has surv
Safer than most equity sectors, but not safe in absolute terms. Demand holds up, which cushions earnings. Share prices can still fall 20 to 30 percent in a broad selloff.
How much of my portfolio should go into a healthcare fund?
For most salaried investors, 10 to 20 percent of the equity portion. Treat it as a satellite position, not the foundation.
Do I need a healthcare fund if I already own a diversified equity fund?
Not necessarily. Check your existing fund's sector allocation first. If it already holds 6 to 8 percent in pharma, adding a dedicated fund pushes you into an accidental overweight.
YourMoneyWise
